Quarterly Call Round-Up: Pfizer, GSK, Lilly Updates
Executive Summary
Pfizer sees more savings from Pharmacia: Pfizer is now projecting "at least" $1 bil. in synergies from the Pharmacia acquisition in 2003, indicating that it expects to exceed its original target of $1 bil. in first-year savings...
You may also be interested in...
Pfizer/Boehringer Spiriva Clears FDA For COPD; Launch Set For Summer
Pfizer/Boehringer Ingelheim's marketing plan for Spiriva will emphasize the drug's long-term efficacy compared to other COPD therapies
Pfizer Launches Inspra; Will Help Company Reach $54 Bil. In 2004
Pfizer is beginning its launch of the congestive heart failure therapy Inspra
Pfizer Launches Inspra; Will Help Company Reach $54 Bil. In 2004
Pfizer is beginning its launch of the congestive heart failure therapy Inspra